Circadian rhythms result from feedback loops involving clock genes and their protein products. In mammals, 2 orphan nuclear receptors, REV-ERBα and RORα, play important roles in the transcription of the clock gene Bmal1. The authors now considerably extend these findings with the demonstration that all members of the REV-ERB (α and β) and ROR (α, β, and γ) families repress and activate Bmal1 transcription, respectively. The authors further show that transcription of Bmal1 is the result of competition between REV-ERBs and RORs at their specific response elements (RORE). Moreover, they demonstrate that Reverb genes are similarly expressed in the thymus, skeletal muscle, and kidney, whereas Ror genes present distinct expression patterns. Thus, the results indicate that all members of the REV-ERB and ROR families are crucial components of the molecular circadian clock. Furthermore, their strikingly different patterns of expression in nervous and peripheral tissues provide important insights into functional differences between circadian clocks within the organism.
Circadian rhythms in mammalian physiological functions are driven by a central pacemaker located in the suprachiasmatic nuclei (SCN) of the hypothalamus (Dunlap et al., 2003) . Although the SCN play a major role in orchestrating rhythmicity throughout the organism, most tissues and even isolated cells possess their own and ostensibly similar circadian clocks (Balsalobre et al., 1998; Yamazaki et al., 2000; Nagoshi et al., 2004; Welsh et al., 2004; Yoo et al., 2004; Carr and Whitmore, 2005) . At the molecular level, circadian rhythms result from interlocking transcriptional/ translational feedback loops involving a set of clock genes (Reppert and Weaver, 2002; Cermakian and Boivin, 2003) .
The transcriptional activation of the 3 Period (Per1, 2, 3) and 2 Cryptochrome (Cry1, 2) genes relies upon CLOCK/BMAL1 heterodimers binding to E-box elements present in their promoter region (Gekakis et al., 1998; Yamaguchi et al., 2000) . In turn, PER and CRY proteins form heteromeric complexes that translocate into the nucleus to repress their own expression (Griffin et al., 1999; Kume et al., 1999) . CLOCK/BMAL1 also appear to drive rhythmic transcription of the orphan nuclear receptor REV-ERBα, which then feeds back to repress Bmal1 gene transcription by binding to retinoic acid-related orphan receptor response elements (ROREs) in the Bmal1 promoter (Preitner et al., 2002) . Recently, another orphan nuclear receptor, the retinoic acid-related orphan receptor α (RORα) was shown to activate Bmal1 transcription through its binding to ROREs (Nakajima et al., 2004; Sato et al., 2004) . Furthermore, the 2 Bmal1 ROREs were shown to be necessary and sufficient for generating the rhythm in Bmal1 gene expression (Ueda et al., 2002) . This suggests that any nuclear receptor able to bind these sites may play a major role in Bmal1 transcription.
The REV-ERB and ROR families of nuclear receptors recognize similar response elements while having opposite transcriptional activities (Giguere, 1999) . The REV-ERB group contains 2 members, REV-ERBα and REV-ERBβ, encoded by 2 distinct genes. The RORs are encoded by 3 different genes: α, which gives rise to 4 splicing isoforms (α 1 to α 4 ), β, and γ, which encodes 2 isoforms (γ and γt).
The recent implication of REV-ERBα and RORα in Bmal1 transcription prompted us to examine the possibility that Bmal1 gene transcription may implicate other members of the REV-ERB and ROR families as well. Our results show that all these proteins bind to Bmal1 promoter elements and regulate its expression. Furthermore, the different spatio-temporal patterns of Rev-erb and Ror gene expression between peripheral and central tissues suggest distinct regulation of Bmal1 gene and underline functional differences between circadian oscillators.
MATERIALS AND METHODS

Animals
Mice (C57BL6, Charles River Laboratories, Wilmington, MA) were entrained to a 12 h light/12 h dark cycle for 2 weeks and then transferred to constant darkness the day before the experiment. Mice were killed by decapitation every 4 h over 24 h (n = 6 per time point), and thymus, kidney, and skeletal muscle were sampled. Procedures involving animals were done in accordance with guidelines of the Canadian Council on Animal Care.
Plasmid Constructs
A 1.03 kb DNA fragment corresponding to the (-965/ +65) region of the mouse Bmal1 promoter was PCRamplified from mouse genomic DNA and cloned into pd2EGFP-1 vector encoding destabilized Green Fluorescent Protein (GFP, BD Biosciences Clontech, Mountain View, CA). Template cDNAs for Bmal1 RNase protection assay (RPA) riboprobes were generated by reverse-transcription PCR from COS-7 cells, CHO cells, and mouse RNA extracts (depending on the species origin of the RNA to be studied by RPA). Template cDNAs for Rev-erb and Ror riboprobes were PCRamplified from reverse-transcribed muscle RNA extracts or from their respective expression vector. Rorα and Rorγ riboprobes were designed to recognize all 4 α isoforms (α 1 to α 4 ) and both γ isoforms (γ and γt), respectively. All PCR fragments were cloned in SmaIdigested pBluescript II (Stratagene, La Jolla, CA) and sequenced to verify identity and orientation (Laval University, Quebec City, Canada). The primers used for all the plasmid constructions are listed in Table 1 . The REV-ERB and ROR expression vectors used in this study were provided by Dr V. Giguère.
Overlapping PCR Mutagenesis
Single and double mutations of the RORE sites of Bmal1 promoter were generated by the overlapping PCR method (Sambrook and Russell, 2001) . The 1.03 kb Bmal1 promoter, cloned in a pBluescript II plasmid, was used as a template. The 1st and 2nd round of PCR were carried out with a primer pair composed of the T7 promoter sequence and the mutated RORE1 or 2, and a 2nd primer pair corresponding to the complementary mutated RORE and the T3 promoter sequence, respectively (Table 1) . The amplified fragments were used as templates for the overlap extension PCR with the T3 and T7 flanking primers. The resulting PCR fragment was digested with appropriate restriction enzymes and cloned into the pd2EGFP-1 vector. The RORE mutations were verified by sequencing (Laval University, Quebec City, Canada).
Cell Culture
COS-7 and CHO cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine (all Gibco products, Grand Island, NY), in a humidified atmosphere containing 5% CO 2 at 37 °C.
Transient Transfection Assays
COS-7 cells were transfected in 6-well plates with the wild-type or the mutated Bmal1-GFP reporters and the different receptor expression plasmids using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. At 36 h posttransfection, cells were either harvested to perform proteins extracts or placed under an inverted microscope (Leica DMIRE2, Leica Microsystems Canada, Richmond Hill, ON) equipped with a GFP filter set (Chroma Technology, Rockingham, VT) to monitor the Bmal1-GFP expression. Five images were captured from each well with a sensitive cooled CCD camera (Retiga EXi, QImaging, Burnaby, BC). Using Openlab software (Improvision, Forchheim, Germany), a threshold fluorescence intensity was set to subtract background from each image. In each image, the mean intensity from all pixels brighter than the threshold value was determined, and the value for the 5 images was summed and used as the fluorescence value for this well.
Western Blotting
After cell lysis in Laemmli buffer, protein extracts were separated on SDS-12.5% polyacrylamide gels and transferred to a nitrocellulose membrane (Amersham Biosciences, Bucks, UK) using the Mini-Protean 3 electrophoresis system (Bio-Rad, Hercules, CA). Membrane was blocked with 1× PBS containing 5% milk powder and 0.05% Tween 20 and probed overnight with either a GFP (1:2000, Chemicon International, Temecula, CA) or a β-actin monoclonal antibody (1:5000, Sigma-Aldrich Canada, Oakville, ON). Immunoreactivities were revealed with an antimouse HRP-conjugated antibody (1:8000, Sigma) and the ECL detection reagent (Amersham).
Extraction of Nuclear Proteins
COS-7 cells were collected in cold 1× PBS and pelleted by a brief centrifugation. After a 10-min incubation in cell lysis buffer (12 mM HEPES, pH 7.9, 2 mM MgCl 2 , 12 mM KCl, 0.5 mM DTT, 200 mM PMSF) complemented with a complete protease inhibitor cocktail (Roche, Basel, Switzerland), cells were centrifuged (10 sec, 13,000 rpm) and the resulting pelleted nuclei were lysed for 40 min on ice in the following buffer: 24 mM HEPES, pH 7.9, 2 mM MgCl 2 , 1.18 M NaCl, 29% (v/v) glycerol, 0.2 mM EDTA, 0.5 mM DTT, 200 mM PMSF, and complete protease inhibitor cocktail (Roche).
Electrophoretic Mobility Shift Assay (EMSA)
Double-stranded RORE (1 and 2) oligonucleotides (Table 1) were end-labeled with [γ-32 P]ATP using T4 polynucleotide kinase (Invitrogen). Nuclear proteins (of COS-7 cells transfected by the different receptor expression plasmids) were incubated for 20 min at 4°C with 0.05 pmol of 32 P-labeled probe in binding buffer (12.5 mM MgCl 2 ; 1 mM EDTA; 1 mM DTT; 20% glycerol; 50 mM Tris-HCl, pH 7.9; 1 µg of poly(dIdC)). For competition experiments, a 100-fold excess of unlabeled wild-type or mutant RORE (1 and 2) oligonucleotides (Table 1) was added simultaneously with the 32 P-labeled probe. Protein-DNA complexes, which appear on the gel as shifted bands, due to their higher molecular weight compared to the free probe, were resolved on a 7% polyacrylamide gel in 0.5X Trisborate EDTA (TBE) buffer. After fixing (10% methanol, 10% acetic acid) and drying, gels were exposed to an imaging screen. Signals were analyzed using Bio-Rad Personal Molecular Imager FX and the Quantity One software (Bio-Rad).
RNase Protection Assay (RPA)
Total RNA from mouse tissues, and COS-7 and CHO transfected cells (4 µg of each expression vector) was extracted with TRIzol reagent (Invitrogen), as recommended by the manufacturer. After quantitation by spectrophotometry, RNAs were verified on ethidium bromide-stained gels. Tissue RNAs from mice killed at the same circadian time (n = 6) were pooled in equivalent amounts. Antisense riboprobes were prepared by in vitro transcription of the linearized templates (Table 1) with T3 or T7 RNA polymerase (Riboprobe system, Promega, Madison, WI) using [α-32 P]UTP (Amersham) and purified on NucAway spin columns (Ambion, Austin, TX). RPAs were performed as described (Sambrook and Russell, 2001) . RNAs were hybridized overnight at 45°C in 80% formamide, 40 mM PIPES, pH 7.4, 400 mM NaCl, and 1 mM EDTA containing 1.7 × 10 4 cpm/µL of labeled riboprobe. Samples were incubated (1 h, 37°C) in an RNase digestion mixture (RNase A, 1 µg/µL, RNase T1 15 U/µL, 300 mM NaCl, 10 mM Tris-HCl, pH 7.5, 5 mM EDTA). RNase digestion was stopped by SDS (0.6%) and proteinase K (0.16 µg/µL), 20 min at 37°C. After a phenol/chloroform extraction (at pH 8), RNA was precipitated with 6 µg of tRNA and 2.5 volumes of ice-cold 100% ethanol (-80°C, 20 min). Pellets were resuspended in 4 µL of formamide loading dye (95% formamide, 0.025% bromophenol blue, 0.025% xylene cyanol, 5 mM EDTA). Samples were denatured and loaded on a 6% denaturing polyacrylamide gel. The gel was fixed, dried, and analyzed as for EMSA (above).
Statistical Analysis
Data are expressed as means ± SEM, and statistical analysis was performed with the SPSS software (version 11.0, SPSS Inc, Chicago, IL). Student's t test or 1way analysis of variance was used to compare 2 or multiple groups, respectively, followed by post hoc tests. Differences were considered to be significant at p < 0.05. Circadian expression of Rev-erb, Ror, and Bmal1 genes in peripheral tissues was analyzed by nonlinear regression using the following equation : y = m + a.cos {[(2πx)/b] + c} (SigmaPlot 9.0 software; Jandel Scientific Erkrath, Germany), as previously described (Guillaumond et al., 2005) . Fitted curves determined by a least square procedure provide 3 circadian parameters: the mean levels (m), the amplitude (a), and the period (b) of the oscillation.
RESULTS
Binding of ROR and REV-ERB Receptors to Bmal1 RORE Sites
Two RORE sites were previously identified in the sequence upstream of the mouse Bmal1 gene (Ueda et al., 2002) (Fig. 1A) . To test the ability of the 5 orphan nuclear receptors (REV-ERBα, REV-ERBβ, RORα 1 , RORβ, and RORγ) to bind to the consensus RORE2 of Bmal1 promoter, we performed EMSAs with nuclear protein extracts of COS-7 cells overexpressing each nuclear receptor. Incubation of a radiolabeled RORE2 oligonucleotide with nuclear extracts resulted in shifted bands corresponding to specific protein-DNA complexes (Fig. 1B) . The migration of these complexes correlates with the expected relative size of the RORor REV-ERB-containing complexes. Shifted bands were efficiently competed by the wild-type RORE2 but not by the mutated RORE2 oligonucleotide in which the half-core motif, AGGTCA, was changed to GTACGT (Fig. 1B) . These results indicate that REV-ERB and ROR factors bind the RORE2 of Bmal1 promoter. When examining the binding to the nonconsensus RORE1 site, we did not detect any shifted complexes in presence of REV-ERB proteins, whereas the ROR proteins appeared to form specific protein-DNA complexes (Fig. 2) .
REV-ERB and ROR Receptors Regulate Bmal1 Transcription
To see if the orphan nuclear receptors affect the expression of Bmal1 gene, we used RNA extracts from COS-7 cells overexpressing REV-ERBs or RORs. RPAs showed that overexpression of each of the 5 nuclear receptors had a significant effect on Bmal1 messenger RNA (mRNA) levels (F 5,46 = 44.32) (Fig.  3A) . Bmal1 mRNA expression was significantly reduced in the presence of REV-ERBα and β receptors (44% and 58%, respectively, p < 0.05), while overexpression of ROR (α 1 , β, or γ) led to a substantial increase in Bmal1 mRNA levels (2-, 1.5-, and 1.5-fold increase, respectively, p < 0.05) (Fig. 3A) . REV-ERB/ ROR regulation of Bmal1 gene is a consistently recurring feature, as similar effects were also found in another unrelated cell line: specifically, in CHO cells, RORα 1 , β and γ induce a 1.2-fold increase of Bmal1 mRNA levels while REV-ERBα and β significantly repress Bmal1 mRNA levels by about 25% (F 5,47 = 21.97, p < 0.05) (Fig. 3B) .
To better characterize the molecular mechanism underlying Bmal1 transcriptional control, a 1030 bp fragment of the upstream sequence of the mouse Bmal1 gene was fused to the GFP reporter gene (Fig. 1A) . We transiently cotransfected COS-7 cells with the Bmal1-GFP construct along with each of the REV-ERB and ROR expression vectors. An example of Bmal1-driven GFP fluorescence recorded in each transfection condition is illustrated in Figure 4A (top).
Quantitative analysis of the GFP fluorescence intensity revealed a significant effect of the 5 nuclear receptors (F 5,89 = 222.98) (Fig. 4A,  bottom) , faithfully mimicking the effects reported above. The Bmal1driven GFP expression is decreased by 57% and 80% with REV-ERBα or REV-ERBβ proteins, respectively (p < 0.001), whereas RORα 1 , β, and γ significantly enhanced the Bmal1- 1.2-, and 2-fold, respectively, p < 0.001) (Fig. 4A, bottom) . These effects were further confirmed by Western analysis of GFP protein levels, which validates our fluorescence quantitation procedure (Fig. 4B ).
Cross-Talk between RORα 1 and REV-ERBβ for Transcriptional Regulation of Bmal1
We next tested whether the strongest activator and repressor of Bmal1 transcription (RORα 1 and REV-ERBβ, respectively) could functionally compete for RORE binding. We performed cotransfection experiments in which the amount of REV-ERBβ was increased while the amount of RORα 1 and reporter construct were kept constant (Fig. 5 ). In these transfections, the total amount of transfected DNA was kept constant by adding varying amounts of carrier plasmid (the empty pCMX plasmid). As expected, the transfection of RORα 1 or REV-ERBβ alone induces a significant 3.2-fold increase and a 61% decrease of Bmal1-driven GFP fluorescence, respectively (F 7,23 = 28.94, p < 0.05). Increasing amounts of REV-ERBβ resulted in a dose-dependent reduction of RORα 1 -mediated transcriptional activation of the Bmal1-GFP reporter (Fig. 5) (p < 0.05). Furthermore, the RORα 1induced activation was completely abolished in the presence of at least a 2-fold excess of REV-ERBβ.
Molecular Dissection of Bmal1 RORE Sites
To decipher the REV-ERB/ROR transcriptional regulation of the Bmal1 promoter, site-directed mutagenesis was performed on the Bmal1-GFP construct. The half-core motifs AGGTTA (RORE1) or AGGTCA (RORE2) were changed to GTACGT, as for EMSA analyses (Fig. 1A) . We examined the effect of mutation in either RORE1 or RORE2, as well as mutation of both ROREs on the transcriptional regulation of the Bmal1 promoter. Single and double RORE mutations significantly altered the REV-ERB and ROR effects on Bmal1 transcription (REV-ERBα: F 3,179 = 5.67; REV-ERBβ: F 3,179 = 25.68; RORα 1 : F 3,179 = 9.57; RORβ: F 3,179 = 5.99; and RORγ: F 3,179 = 8.89). As expected (Fig. 4A) , overexpression of REV-ERB (α, β) proteins decreased the Bmal1-driven GFP fluorescence (Fig. 6 ). This effect was slightly diminished when either the RORE1 or the RORE2 was mutated (p < 0.05) and was completely lost when both RORE sites were mutated (p < 0.001) (Fig. 6) . Surprisingly, the ROR-mediated increases of Bmal1 transcriptional activity were still observed with the RORE2 mutation, whereas the single RORE1 and the double RORE1+2 mutations strongly decreased the ROR-stimulated Bmal1 gene promoter activities (RORα and RORγ: p < 0.001; RORβ: p < 0.05) (Fig. 6 ). Together, these results suggest that REV-ERB and ROR factors impinge directly on Bmal1 promoter expression. Specifically, REV-ERB proteins act through the RORE1 as well as the RORE2, while ROR proteins seem to exert their effects preferentially via the RORE1.
Tissue-Dependent Expression of
Rev-erb, Ror, and Bmal1 mRNAs
RPA analysis was used to determine the distribution and the temporal profiles of Bmal1, Rev-erb, and Ror mRNA expression at 6 time points over a 24-h circadian cycle in 3 mouse peripheral tissues (skeletal muscle, kidney, and thymus). Figure 7 shows that Reverbα and β mRNAs displayed a rhythmic expression, albeit with different amplitudes (Table 2) , in the 3 tissues, with maximal values occurring at around the same time (CT6-CT10). These peaks coincide with troughs in oscillating Bmal1 mRNA levels in the 3 tissues. In contrast, Rorα 1 -α 4 mRNAs do not display any clear circadian variation in these tissues ( Fig. 7 and Table 2 ). No expression of Rorβ could be detected in any of the tissues examined (data not shown). Finally, no oscillation of Rorγ-γt mRNA expression was observed in thymus, while in kidney and muscle, Rorγ mRNA levels show rhythmic variations with maximal values occurring in phase with the rise in Bmal1 mRNA levels. However, the amplitude of the Rorγ mRNA rhythm in muscle was very low compared to that in kidney (Table 2) .
DISCUSSION
The data reported here underscore the role of members of REV-ERB and ROR nuclear receptor families in the circadian system. Specifically, we provide evidence that these factors can regulate Bmal1 gene expression through their binding to RORE sites. Moreover, the assessment of the temporal expression patterns of Rev-erb and Ror mRNAs in peripheral tissues, together with published data in the central nervous system, suggests functional differences in the molecular clock machinery between circadian oscillators.
Overexpression of REV-ERB and ROR receptors in COS-7 and CHO cells leads to opposite effects on the Bmal1 mRNA levels. REV-ERB receptors both repress the transcriptional activity of Bmal1 gene, while all ROR receptors act as transcriptional activators. Our results confirm and extend those of Preitner et al. (2002) and Sato et al. (2004) and provide evidence that not only REV-ERBα and RORα but also the other members of these 2 families may be components of circadian oscillators. Gel shift and site-directed mutagenesis experiments suggest that the transcriptional regulation exerted by REV-ERB and ROR proteins on Bmal1 gene is mediated through the 2 ROREs. Our experiments, using a Bmal1-GFP reporter system, indicate that REV-ERBβ functionally competes with RORα for Bmal1 transcription through binding on RORE. These data demonstrate that the previously reported binding competition between REV-ERB and ROR receptors to ROREs oligonucleotides actually leads to a transcriptional activity shift (Forman et al., 1994; Giguere, 1999; Sato et al., 2004) . However, whereas REV-ERBs could exert their effects on the 2 RORE sites, ROR receptors seem to act preferentially through the RORE1. While EMSA data suggest that the binding of REV-ERBs and RORs to RORE2 is stronger than to RORE1, RORE2 mutation seems to have little effect on ROR-induced activation of Bmal1 transcription. The reasons for this discrepancy are unclear, but it is possible that only minute amounts of RORs are sufficient to promote transcriptional activation of Bmal1 through the RORE1 site.
According to Ueda et al. (2002) , mutation of RORE sites in Bmal1 promoter abolishes the circadian rhythmicity of Bmal1 gene in cultured Rat-1 fibroblasts. Therefore, coordinated expression of REV-ERB and ROR receptors throughout the 24-h cycle is necessary and sufficient to shape Bmal1 transcriptional rhythmicity. In the liver, high levels of REV-ERBα precede the trough of Bmal1 oscillations (Preitner et al., 2002) , which is consistent with a model of Bmal1 transcriptional regulation in which REV-ERBα acts as a repressor. This model was supported by studies in Rev-erbα knockout (KO) mice, in which the amplitude of Bmal1 rhythm in liver and SCN is dramatically reduced, due to higher levels of Bmal1 at the time of the expected trough in wild-type mice. In contrast to Rev-erbα, the peak of Rorα mRNA in the SCN precedes the rise of Bmal1 mRNA (Sato et al., 2004) , consistent with a putative stimulating role of RORα in Bmal1 transcription. Furthermore, staggerer mice (which bear a Rorα loss-of-function mutation) show both reduced Bmal1 peak expression in the SCN and a shortened locomotor activity period in constant conditions, as do Rev-erbα KO mice (Preitner et al., 2002; Sato et al., 2004) . Considering these observations, it was important to test whether other members of the Rev-erb and Ror families also contribute in the function of circadian clock. Indeed, in Rorβ-deficient mice, the period of locomotor rhythms is also modified. However, in contrast to staggerer mice, the observed period is longer than that of wild-type mice (Andre et al., 1998) . This gives further support to a more generalized model for the implication of orphan nuclear receptors in the circadian system. Gel shift and chromatin immunoprecipitation assays using extracts from tissues harvested at different time points, as well as loss-of-function experiments, will be needed to prove the involvement of the different orphan nuclear receptors in the circadian clock. The multiplicity of members for both families raises the possibility of functional redundancy. However, there are several lines of evidence, including nonoverlapping patterns of expression, arguing against this possibility, at least for ROR members. We show that the distribution and temporal expression profiles of Rev-erb and Ror genes differ between peripheral oscillators in mice. Rev-erbα and β expression is roughly similar in the 3 peripheral tissues examined (skeletal muscle, kidney, and thymus), exhibiting higher levels during the subjective day, albeit with different amplitudes (Table 2, see below). Rhythmic expression of these 2 nuclear receptors has been reported in other peripheral tissues (Preitner et al., 2002; Yamamoto et al., 2004) and in the SCN (Onishi et al., 2002; Ueda et al., 2002) . Similar to what is observed in the liver and SCN, the peaks of expression (middle to late subjective day) are antiphasic to those of Bmal1, consistent with their repressive activity on its promoter. These results are also in agreement with previous data showing stable phase-relationships between Rev-erb (α and β) and Bmal1 mRNA in the SCN and in many peripheral tissues (Preitner et al., 2002; Ueda et al., 2002; Yamamoto et al., 2004) . Rorα mRNAs are highly expressed in the brain compared to peripheral tissues (Forman et al., 1994; Matsui et al., 1995; Ino, 2004) . Albeit rather weak, cyclic expression of Rorα has been described in the SCN with highest levels during the middle of the night (Ueda et al., 2002; Sato et al., 2004) . In muscle, kidney, and thymus, Rorα 1 -α 4 mRNAs do not exhibit any obvious circadian variation, as reported in liver (Preitner et al., 2002; F.G., H.D., unpublished data) . Another member of the ROR family, RORγ, which is expressed exclusively in the periphery, could play the same role as that of RORα in the SCN. Rorγ is expressed in muscle, kidney, and thymus, as previously reported (Hirose et al., 1994; Medvedev et al., 1996) . Interestingly, Rorγ appears not to be expressed in all peripheral tissues, as it is absent in the spleen, for example (Ortiz et al., 1995; F.G., H.D., unpublished data) . Strong and weak oscillations of Rorγ occur in kidney and muscle, respectively, with a peak expression that coincides with the rise of Bmal1 mRNA, as reported in liver (Preitner et al., 2002) . This suggests the involvement of RORγ in the rhythmic activation of Bmal1 transcription in kidney, liver, and to a lower extent in muscle. In contrast to these tissues, we have not detected a circadian variation of Rorγ mRNA in thymus, which may be explained by the fact that our probe also recognizes the Rorγt isoform that is specifically and strongly expressed in this tissue (He et al., 1998; Giguere, 1999 ). An interesting possibility would be that Rorα and γ splicing isoforms are differentially regulated and that probes discriminating between these isoforms may uncover oscillations of some of them, similarly to what was shown for mTimeless isoforms (Barnes et al., 2003) . High and stable Rorγ expression (and, to a much limited extent, Rorα) in the thymus might explain the weaker oscillations of Bmal1 mRNA levels observed in this tissue ( Fig. 7 and Table 2 ). By contrast to the peripheral expression of Rorγ, Rorβ expression is restricted to the central nervous system, especially to structures of the circadian system (retina, SCN, and pineal gland) (Andre et al., 1998) , where it oscillates with rather modest amplitude (Andre et al., 1998; Sumi et al., 2002; Ueda et al., 2002) . As expected, Rorβ mRNA was not detected in any of the peripheral tissues examined.
Based on our observations, we propose a model for the tissue-specific regulation of Bmal1 transcription. In muscle and thymus, Bmal1 mRNA rhythms may result from a combination of cyclic down-regulation by REV-ERB receptors and a relatively constant activation by RORα or RORγ receptors. In the kidney, robust and rhythmic Bmal1 transcription could be induced at night by RORγ and repressed in the day by REV-ERB receptors in a manner comparable to what is observed in the liver. Finally, in the central nervous system, repression of Bmal1 gene transcription depends on both REV-ERBs, while activation relies solely upon the effects of RORβ and RORα. Moreover, the fact that the cooperative interactions with other polypeptides may be needed for the control of the Bmal1 promoter in vivo provides an additional layer of complexity in the modulation of the expression of this gene among tissues. Further experiments, including analysis of protein profiles, as well as characterization of circadian phenotypes of mutant mice and/or cells with down-regulated Ror/Rev-erb transcripts (for example, through RNA interference) will be required to validate functional relevance of these differences among clocks.
Thus, on one hand, REV-ERBα and β are expressed in a similar manner both in the SCN and in various oscillators of the periphery, whereas on the other hand, RORα, β, and γ present strikingly different expression patterns between tissues. As we found that these nuclear receptors exert repressing and activating effects on Bmal1 gene, respectively, our results reveal important functional differences between oscillators in the SCN and the periphery and, possibly, between peripheral oscillators.
